Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
Measles; diarrhea; This spontaneous report was received from a consumer and referred to a 1-year-old male patient. The patient's pertinent medical history included Asthma. The patient's concurrent conditions, drug reactions/allergies were not reported. Concomitant therapies were not reported. On 05-MAY-2025, the patient was vaccinated with dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) (dose, strength, formulation, dose number, route, anatomical site, expiration date and lot # were not reported) for routine vaccination, which was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (indication, expiration date, and lot # were not reported). On approximately 15-MAY-2025 (reported as approximately 10 days later), the patient broke out in a rash, had a high fever, and diarrhea. The patient was seen by the pediatrician who diagnosed him with measles. The patient was treated with steroids, antibiotics, naproxen (MOTRIN), and ointments and it eventually started clearing up. However, on 25-JUL-2025, the patient started to break out again in a full body rash and developed a high fever. The patient was currently being monitored outpatient by the pediatrician. Treatment did not change, and the symptoms were currently treated with unspecified steroids, antibiotics, ointments, and naproxen (MOTRIN). The outcome of the events measles and diarrhea was reported as not resolved. The causality between the events and the suspect products was not provided.
Medical History/Concurrent Conditions: Asthma
DILUENT MRK